Chris Pasquale

Stock Analyst at Guggenheim

(0.37)

# 4,292

Out of 5,154 analysts

3

Total ratings

n/a

Success rate

-9.93%

Average return

Main Sectors:

Top Industries:

Medical Devices Medical Instruments & Supplies

Stocks Rated by Chris Pasquale

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DXCM DexCom	Upgrades: Buy	$145	$68.10	+112.92%	1	Jan 7, 2022
	COO The Cooper Companies	Upgrades: Buy	$124	$76.55	+61.66%	1	Jan 3, 2022
	PRCT PROCEPT BioRobotics	Initiates: Buy	$45	$24.22	+85.80%	1	Oct 11, 2021

DexCom

Jan 7, 2022

Upgrades: Buy

Price Target: $145

Current: $68.10

Upside: +112.92%

The Cooper Companies

Jan 3, 2022

Upgrades: Buy

Price Target: $124

Current: $76.55

Upside: +61.66%

PROCEPT BioRobotics

Oct 11, 2021

Initiates: Buy

Price Target: $45

Current: $24.22

Upside: +85.80%